首页> Clinical & translational immunology> Switching on the green light for chimeric antigen receptor T-cell therapy.

Switching on the green light for chimeric antigen receptor T-cell therapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sherly,Mardiana

第一单位： Cancer Immunology Program Peter MacCallum Cancer Centre Melbourne VIC Australia.;Sir Peter MacCallum Department of Oncology The University of Melbourne Parkville VIC Australia.

作者： Sherly,Mardiana ^[1] ; Junyun,Lai ^[1] ; Imran Geoffrey,House ^[1] ; Paul Andrew,Beavis ^[1] ; Phillip Kevin,Darcy ^[2]

作者单位： Cancer Immunology Program Peter MacCallum Cancer Centre Melbourne VIC Australia.;Sir Peter MacCallum Department of Oncology The University of Melbourne Parkville VIC Australia. ^[1] Cancer Immunology Program Peter MacCallum Cancer Centre Melbourne VIC Australia.;Sir Peter MacCallum Department of Oncology The University of Melbourne Parkville VIC Australia.;Department of Pathology University of Melbourne Parkville VIC Australia.;Department of Immunology Monash University Clayton VIC Australia. ^[2]

关键词 CAR T cells adoptive cell therapy solid tumors

DOI 10.1002/cti2.1046

PMID 31073403

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical & translational immunology

2019年8卷5期

e1046页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Clinical & translational immunology

2019年8卷5期

e1046页

检索历史清除

Switching on the green light for chimeric antigen receptor T-cell therapy.

Clinical & translational immunology

相似文献

同项目论文

Clinical & translational immunology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Switching on the green light for chimeric antigen receptor T-cell therapy.

Clinical & translational immunology

相似文献

同项目论文

Clinical & translational immunology

相关期刊

检索历史清除